Biomagnetics Diagnostics Completes Equity Financing Round - Prepares Entry into Malaria and Tuberculosis Diagnostics Markets

• Press Release
• Source: Biomagnetics Diagnostics Corp.
• On 9:30 am EDT, Monday October 19, 2009

SAN FRANCISCO--(BUSINESS WIRE)--Biomagnetics Diagnostics Corp. (Pink Sheets:BMGP - News), a producer of revolutionary diagnostic systems and technology for malaria, tuberculosis, HIV and hepatitis testing today announced the completion of its equity financing designed to fund entry into the Integrated Optical Biosensor Systems (IOBS) market. Through this round of equity financing the Company received cash and commitments of approximately $1 million from several private investors and a single philanthropic organization.

Related Quotes

Symbol	Price	Change
BMGP.PK	0.18	+0.04

{"s" : "bmgp.pk","k" : "c10,l10,p20,t10","o" : "","j" : ""}

“We view the market for both malaria and bovine tuberculosis testing to be significantly underserved with few viable field deployable technologies available. In 2010 we plan to introduce a new generation of products to target this area. This equity financing will be instrumental in this market entry,” commented Clayton Hardman, CEO of Biomagnetics Diagnostics. “We believe this technology upon commercialization will not only be profitable for Biomagnetics and our investors, but will also provide an important tool in the medical, research and anti-bioterrorism communities that can potentially improve and save lives.”

According to the World Health Organization, some 3.2 billion people, or about half the world's population is at risk of malaria transmission in 107 countries and territories worldwide. While there are between 350 million and 500 million new cases of malaria each year, there are very few reliable and field deployable diagnostic tools available. In the case of malaria, early detection substantially improves treatability and survivability. TB (tuberculosis) is the second leading cause of death from infectious disease worldwide. Bovine TB is a growing problem through out the world with an estimated 1.3 billion cattle at risk. In the United States, where the cattle industry is valued at $60 billion annually, the use of existing diagnostic tests currently add $5.00 to $15.00 on average per head to the cattle industry's costs. Field deployable integrated optical biosensor systems hold the promise to significantly speed the diagnostic testing process and to meaningfully lower costs.

About Biomagnetics Diagnostics Corp.

Biomagnetics Diagnostics Corporation is an advanced medical device and biotechnology company. The Company’s revolutionary diagnostic systems, which are based on advanced magnetics, test for any viral or bacterial disease using any body fluid. The Company's technology allows laboratories to perform far more tests in the same amount of time it takes to do a single test. The HTS-MTP platform is designed to detect the actual virus and viral load in body fluids and not just simply screen for the presence of viral antibodies. More information on Biomagnetics Diagnostics Corp. can be seen at www.BiomagneticsBMGP.com.

Biomagnetics Diagnostics Corp.
Joe Noel, 925-922-2560